These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20829601)

  • 1. Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C.
    Moscato GA; Giannelli G; Grandi B; Pieri D; Marsi O; Guarducci I; Batini I; Altomare E; Antonaci S; Capria A; Pellegrini G; Sacco R
    Intervirology; 2011 Feb; 54(2):61-5. PubMed ID: 20829601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy].
    Higashimoto M; Takahashi M; Jokyu R; Saito H
    Rinsho Byori; 2006 Feb; 54(2):111-5. PubMed ID: 16548229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.
    Medici MC; Furlini G; Rodella A; Fuertes A; Monachetti A; Calderaro A; Galli S; Terlenghi L; Olivares M; Bagnarelli P; Costantini A; De Conto F; Sainz M; Galli C; Manca N; Landini MP; Dettori G; Chezzi C
    J Clin Virol; 2011 Aug; 51(4):264-9. PubMed ID: 21621454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C.
    Loggi E; Cursaro C; Scuteri A; Grandini E; Panno AM; Galli S; Furlini G; Bernardi M; Galli C; Andreone P
    J Clin Virol; 2013 Mar; 56(3):207-11. PubMed ID: 23245628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Ali EM; Mouhamed L; Abou el-fetouh S; AbdEl-Hameed AR; Mizokami M
    J Med Virol; 2010 Nov; 82(11):1878-88. PubMed ID: 20872714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.
    Vermehren J; Susser S; Berger A; Perner D; Peiffer KH; Allwinn R; Zeuzem S; Sarrazin C
    J Clin Virol; 2012 Sep; 55(1):17-22. PubMed ID: 22698697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA.
    Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ
    Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virological tools to diagnose and monitor hepatitis C virus infection.
    Chevaliez S
    Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
    Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
    J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
    Veillon P; Payan C; Picchio G; Maniez-Montreuil M; Guntz P; Lunel F
    J Clin Microbiol; 2003 Jul; 41(7):3212-20. PubMed ID: 12843066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C.
    Chevaliez S; Soulier A; Poiteau L; Bouvier-Alias M; Pawlotsky JM
    J Clin Virol; 2014 Sep; 61(1):145-8. PubMed ID: 24973282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting.
    Ergünay K; Sener B; Alp A; Karakaya J; Hasçelik G
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):486-91. PubMed ID: 21767705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of core antigen detection in management of hepatitis C: a critical review.
    Seme K; Poljak M; Babic DZ; Mocilnik T; Vince A
    J Clin Virol; 2005 Feb; 32(2):92-101. PubMed ID: 15653411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C: analysis by a prospective study.
    Muto H; Tanaka E; Matsumoto A; Yoshizawa K; Kiyosawa K;
    J Gastroenterol; 2004 Jul; 39(7):674-80. PubMed ID: 15293139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.
    De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.